Wednesday, September 13, 2017 10:15 PM ET
Significant Insider Sales of Sucampo Pharmaceuticals (SCMP) Shares Reverses Buying Trend of Last 90 Days
There was a notable level of share sales at Sucampo Pharmaceuticals today, as reported in filings with the SEC. Two insiders — Dr Sachiko Kuno, 10% Owner, and Dr Ryuji Ueno, 10% Owner — sold 2,000,000 shares in the company having a market value of approximately $24,000,000. There have been 2 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been buys resulting in the acquisition of 8,700 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 1,991,300 shares and have averaged 502,175 shares per transaction over this time period.
Relative to its peers over the last 90 days, insider buy/sell trading at Sucampo Pharmaceuticals is above the 266-company peer group average. Bio Therapeutic Drugs peer group saw 298 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for Sucampo Pharmaceuticals insiders was also higher. Within the peer group there were 7,621,758 shares purchased and 14,304,013 shares sold with company insiders having sold 22,424 shares on average.
The data used in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* Dr Sachiko Kuno, 10% Owner, sold 1,000,000 shares
* Dr Ryuji Ueno, 10% Owner, sold 1,000,000 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.